-
Breast Cancer
- Gender: F
- Age: 20-39
- Evaluation
- Clinical Breast Examination - Every 3 years
- Breast-self examination - Every Month
- Age: > or = 40
- Evaluation:
- Mammogram - Every year
- Clinical Breast Examination - Every Year
- Breast-self Examination - Every month
-
Colon/Rectum or Colorectal
- Gender: M/F
- Age: > or = 50
- Evaluation:
- Digital Rectal Examination - every year
- Fecal Occult Blood Test - every year
- Flexible Sigmoidoscopy - every 5 years
- Double-contrast barium enema - every 5-10 years
- Colonoscopy - every 10 years
-
Prostate
- Gender : M
- Age: > or = 50 who have at least a 10-year life expectancy (or <50 if at high risk)
- Evaluation:
- Prostate-specific antigen - every year
- digital rectal examination - every year
-
Cervix
- Gender: F
- > or = 18 (or younger if sexually active)
- Evaluation:
- Papanicolaou (Pap) test - every year
- Pelvic Exam - every 1 - 3 years
- Endometrial tissue sample or Endometrial Biopsy (if at high risk) - discretion of the physician
-
Cancer-related checkups
- Gender: M/F
- Age: > or = to 20-39
- Evaluation:
- Check up that includes examination for cancers of the thyroid, testicles, ovaries, lymph nodes, oral cavity, and skin as well as counseling about health practices and risk factors - Every 3 years
- Age: > or = 40
- Evaluation:
- Check up that includes examination for cancers of the thyroid, testicles, ovaries, lymph nodes, oral cavity, and skin as well as counseling about health practices and risk factors - Every year
-
Tumor Marker Identification
- Description:
- Analysis of substances found in the blood or other body fluids that are made by the tumor or by the body in response to the tumor.
- Diagnostic Uses:
- Breast, colon, lung, ovarian, testicular, prostate cancers
-
Description:
Analysis of substances found in the blood or other body fluids that are made by the tumor or by the body in response to the tumor.
Diagnostic Uses:
Breast, colon, lung, ovarian, testicular, prostate cancers
Tumor Marker Identification
-
Magnetic Resonance Imaging (MRI)
- Description:
- Use of magnetic fields and radiofrequency signals to create sectioned images of various body structures
- Diagnostic Uses:
- Neurologic, Pelvic, abdominal, thoracic cancer
-
Description:
Use of magnetic fields and radiofrequency signals to create sectioned images of various body structures
Diagnostic Uses:
Neurologic, Pelvic, abdominal, thoracic cancer
Magnetic Resonance Imaging (MRI)
-
Computed tomography (CT Scan)
- Description:
- Use of narrow beam x-ray to scan successive layers of tissue for a cross sectional view.
- Diagnostic Uses:
- Neurologic, pelvic, abdominal, skeletal, thoracic cancers
-
Description:
Use of narrow beam x-ray to scan successive layers of tissue for a cross sectional view.
Diagnostic Uses:
Neurologic, pelvic, abdominal, skeletal, thoracic cancers
Computed tomography (CT Scan)
-
Fluoroscopy
- Description:
- Use of x-rays that identify contrasts in body tissue densities; may involve the use of contrast agents
- Diagnostic Uses:
- Skeletal, lung, gastrointestinal cancers
-
Description:
Use of x-rays that identify contrasts in body tissue densities; may involve the use of contrast agents
Diagnostic Uses:
Skeletal, lung, gastrointestinal cancers
Fluoroscopy
-
Ultrasonography (ultrasound)
- Description:
- High frequency sound waves echoing off body tissue densities are converted electronically into images; used to assess tissues deep within the body.
- Diagnostic Uses:
- Abdominal and Pelvic Cancers
-
Description:
High frequency sound waves echoing off body tissue densities are converted electronically into images; used to assess tissues deep within the body.
Diagnostic Uses:
Abdominal and Pelvic Cancers
Ultrasonography (ultrasound)
-
Endoscopy
- Description:
- Direct visualization of a body cavity or passageway by insertion of an endoscope into a body cavity or opening; allows tissue biopsy, fluid aspiration and excision of small tumors; both diagnostic and therapeutic.
- Diagnostic Uses:
- Bronchial, gastrointestinal cancers
-
Description:
Direct visualization of a body cavity or passageway by insertion of an endoscope into a body cavity or opening; allows tissue biopsy, fluid aspiration and excision of small tumors; both diagnostic and therapeutic.
Diagnostic Uses:
Bronchial, gastrointestinal cancers
Endoscopy
-
Nuclear medicine imaging
- Description:
- Uses IV injection or ingestion of radioisotope substances followed by imaging of tissues that have concentrated the radioisotopes.
- Diagnostic Uses:
- Bone, brain, thyroid, liver, kidney, spleen cancers
-
Description:
Uses IV injection or ingestion of radioisotope substances followed by imaging of tissues that have concentrated the radioisotopes.
Diagnostic Uses:
Bone, brain, thyroid, liver, kidney, spleen cancers
Nuclear medicine imaging
-
Positron emission tomography (PET Scan)
- Description:
- Computed cross-sectional images of increased concentration of radioisotopes in malignant cells provide information about biologic activity of malignant cells; help distinguish between benign and malignant processes and responses to treatment.
- Diagnostic Uses:
- Lung, Colon, Liver, pancreas, breast, esophagus cancer; Hodgkin's and Non-Hodgkin's lymphoma and melanoma
-
Description:
Computed cross-sectional images of increased concentration of radioisotopes in malignant cells provide information about biologic activity of malignant cells; help distinguish between benign and malignant processes and responses to treatment.
Diagnostic Uses:
Lung, Colon, Liver, pancreas, breast, esophagus cancer; Hodgkin's and Non-Hodgkin's lymphoma and melanoma
Positron emission tomography (PET Scan)
-
Radioimmunoconjugates
- Description:
- Monoclonal antibodies are labeled with a radioisotope and injected IV into the patient; the antibodies that aggregate at the tumor site are visualized with scanners.
- Diagnostic Uses:
- Colorectal, breast, ovarian, head and neck cancers; lymphoma and melanoma
-
Description:
Monoclonal antibodies are labeled with a radioisotope and injected IV into the patient; the antibodies that aggregate at the tumor site are visualized with scanners.
Diagnostic Uses:
Colorectal, breast, ovarian, head and neck cancers; lymphoma and melanoma
Radioimmunoconjugates
-
Lung Cancer
- Gender: M/F
- Age: Current or former smokers (quit within past 15 years) ages 55-74 in fairly good health at least a 30 pack-year history
- Evaluation:
- Low-dose CT (LDCT) - every year
|
|